JP2025503607A5 - - Google Patents
Info
- Publication number
- JP2025503607A5 JP2025503607A5 JP2024540848A JP2024540848A JP2025503607A5 JP 2025503607 A5 JP2025503607 A5 JP 2025503607A5 JP 2024540848 A JP2024540848 A JP 2024540848A JP 2024540848 A JP2024540848 A JP 2024540848A JP 2025503607 A5 JP2025503607 A5 JP 2025503607A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- serpine
- disease
- pharmaceutical composition
- condition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263266444P | 2022-01-05 | 2022-01-05 | |
| US63/266,444 | 2022-01-05 | ||
| PCT/US2022/082669 WO2023133078A2 (en) | 2022-01-05 | 2022-12-30 | Serpin peptides and methods of using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025503607A JP2025503607A (ja) | 2025-02-04 |
| JP2025503607A5 true JP2025503607A5 (https=) | 2025-06-02 |
Family
ID=87074167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024540848A Pending JP2025503607A (ja) | 2022-01-05 | 2022-12-30 | セルピンペプチドおよびその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20250161419A1 (https=) |
| EP (1) | EP4460322A4 (https=) |
| JP (1) | JP2025503607A (https=) |
| CN (1) | CN118804758A (https=) |
| AU (1) | AU2022431253A1 (https=) |
| CA (1) | CA3247129A1 (https=) |
| IL (1) | IL314135A (https=) |
| WO (1) | WO2023133078A2 (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017040287A1 (en) * | 2015-08-28 | 2017-03-09 | Serpin Pharma, Llc | Methods for treatment of diseases |
| WO2017123401A1 (en) * | 2016-01-13 | 2017-07-20 | Children's Hospital Medical Center | Compositions and methods for treating allergic inflammatory conditions |
| EP3773727A4 (en) * | 2018-04-09 | 2022-05-04 | Yale University | BIFUNCTIONAL SMALL MOLECULES TO TARGETING THE SELECTIVE DEGRADATION OF CIRCULATING PROTEINS |
| KR20220099963A (ko) * | 2019-10-10 | 2022-07-14 | 예일 유니버시티 | 세포 수용체를 통한 분자 분해제로서의 조작된 항체 |
| US20210162029A1 (en) * | 2019-11-04 | 2021-06-03 | Azitra Inc | Compositions and methods for treatment or prevention of skin diseases and disorders with lekti |
| EP4003391A4 (en) * | 2020-07-06 | 2023-02-22 | Serpin Pharma, LLC | PEPTIDES AND METHODS OF USE THEREOF |
| AU2022222778A1 (en) * | 2021-02-22 | 2023-08-31 | Yale University | Targeted bifunctional degraders and methods using same |
-
2022
- 2022-12-30 IL IL314135A patent/IL314135A/en unknown
- 2022-12-30 JP JP2024540848A patent/JP2025503607A/ja active Pending
- 2022-12-30 CA CA3247129A patent/CA3247129A1/en active Pending
- 2022-12-30 EP EP22919262.0A patent/EP4460322A4/en active Pending
- 2022-12-30 US US18/726,945 patent/US20250161419A1/en active Pending
- 2022-12-30 AU AU2022431253A patent/AU2022431253A1/en active Pending
- 2022-12-30 WO PCT/US2022/082669 patent/WO2023133078A2/en not_active Ceased
- 2022-12-30 CN CN202280092284.4A patent/CN118804758A/zh active Pending
-
2023
- 2023-07-13 US US18/148,942 patent/US20230406906A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gozes et al. | Pharmaceutical VIP: prospects and problems | |
| JP2010540654A5 (https=) | ||
| JP2022546878A5 (https=) | ||
| JPH08510205A (ja) | Ｙｙペプチドのアナログとその用途 | |
| US20210145943A1 (en) | Oral delivery of angiotensin converting enzyme 2 (ace2) or angiotensin-(1-7)-bioencapsulated in plant cells attenuates pulmonary hypertension, cardiac dysfunction and development of autoimmune and experimentally induced ocular disorders | |
| CN1993137B (zh) | 用于治疗心血管疾病的组合物和方法 | |
| JP6069663B2 (ja) | 抗炎症医薬製品 | |
| IL192046A (en) | Intact and peptide intestinal fragments and methods of use | |
| EP2349320A1 (en) | Compositions and methods for treatment of kidney disorders | |
| US20210008177A1 (en) | Elapidae neurotoxin enhances opioid analgesic effect and inhibits opioid induced hyperalgesia and tolerance | |
| JP2022506716A5 (https=) | ||
| JP7751641B2 (ja) | Ｇｌｐ－１／ｇｌｐ－２デュアルアゴニストの医薬組成物 | |
| WO2019080919A1 (zh) | 充分剂量条件下治疗乙肝病毒相关肝病的药物和方法 | |
| CN110256574B (zh) | 融合多肽及在制备抗抑郁、神经退行性疾病药物中的应用 | |
| JP2025503607A5 (https=) | ||
| CN102037133B (zh) | 改进的β胸腺素片段 | |
| CN119285744A (zh) | 逆向-反转肽 | |
| BR112019026336A2 (pt) | forma de sal de cloridrato de um peptídeo análogo da porção c-terminal de c5a e o uso da mesma, composição, método para induzir uma resposta imune contra uma infecção ou câncer, kit e composto para aumentar uma resposta imune para um agente imunogênico | |
| JP2005506276A5 (https=) | ||
| JP2023504904A5 (https=) | ||
| JP2012529423A5 (https=) | ||
| JP2024522988A (ja) | ペプチドおよび使用方法 | |
| JP5477794B2 (ja) | エンドキニンｃ／ｄ由来のペプチド | |
| JP2018522555A5 (https=) | ||
| EP3010524A1 (en) | Protamine in treatment of neuronal injuries |